Frédéric Kahn

home / authors / fr-d-ric-kahn

Frédéric Kahn is Generic APIs Commercial Head at Seqens.

Articles

I Saw the Future of Global Pharmaceutical Production in India

Frédéric Kahn

Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.

Why Global Pharma Companies Aren’t Quitting China Anytime Soon

Frédéric Kahn

What if we are underestimating China’s response to US/EU inshoring?

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

AAPS PharmSci 360: Challenges in Peptide-Based Drugs

Published: November 12th 2024 | Updated: November 29th 2024

AAPS PharmSci 360: Challenges in Peptide-Based Drugs

Published: November 13th 2024 | Updated: November 29th 2024

Risk-Based Development Supporting Process Qualification for Spray-Dried Dispersion

Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice

Published: November 22nd 2024 | Updated: November 29th 2024

Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: November 22nd 2024 | Updated: November 29th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.